Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever

Lancet

Volumn 360, Issue 9329, 2002, Pages 310-312

  Kochel, Tadeusz J ^a   Watts, Douglas M ^b   Halstead, Scott B ^c   Hayes, Curtis G ^b   Espinoza, Angelica ^a   Felices, Vidal ^a   Caceda, Roxana ^a   Bautista, Christian T ^a   Montoya, Ysabel ^d   Douglas, Susan ^d   Russell, Kevin L ^a  

^a California   (Peru)

^b NAVAL MEDICAL RESEARCH CENTER   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d Peruvian Institute of Neurosciences   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE 1 ANTIBODY; DENGUE 2 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; GENOTYPE; HUMAN; PERU; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; SEROTYPE;

EID: 0037183318     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)09522-3     Document Type: Article

References (5)

1. Failure of secondary infection with American genotype dengue 2 to cause dengue hemorrhagic fever
2. Dengue virus structural differences that correlate with pathogenesis
3. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: Comparison of the BHK suspension test with standard plaque reduction neutralization
4. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction
5. A PCR-restriction enzyme technique for determining dengue virus subgroups within serotypes